Affinity purification of Shiga-like toxin I and Shiga-like toxin II

Journal of Microbiological Methods

Volumn 32, Issue 3, 1998, Pages 247-252

  Mulvey, George ^a   Vanmaele, Rosa ^a   Mrazek, Monique ^a   Cahill, Mark ^a   Armstrong, Glen D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Escherichia coli; O157:H7; Purification; Receptor; Shiga like toxin; Verotoxin

Indexed keywords

BACTERIAL TOXIN; CELL RECEPTOR; ENDOTOXIN; VEROTOXIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PURIFICATION; TOXIN ANALYSIS;

ESCHERICHIA COLI;

EID: 0032076238     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7012(98)00028-1     Document Type: Article

References (31)

1. Acheson D.W.K., Donohue-Rolfe A. Cancer-associated hemolytic uremic syndrome: A possible role of mitomycin in relation to shiga-like toxins. J. Clin. Oncol. 7:1989;1943.
2. Acheson D.W.K., Jacewicz M., Kane A.V., Donohue-Rolfe A., Keusch G.T. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays. Microb. Pathog. 14:1993;57-66.
3. Al-Jumaili I., Burke D.A., Scotland S.M., Al-Mardini H., Record C.O. A method of enhancing verocytotoxin production by Escherichia coli. FEMS Microbiol. Lett. 93:1992;121-126.
4. Allerberger F., Rossboth D., Dierich M.P., Aleksic S., Schmidt H., Karch H. Prevalence and clinical manifestations of Shiga toxin producing Escherichia coli infections in Austrian children. Eur. J. Clin. Microbiol. Infect. Dis. 15:1996;545-550.
5. Armstrong G.D., Fodor E., Vanmaele R. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J. Infect. Dis. 164:1991;1160-1167.
6. Armstrong G.D., Rowe P.C., Goodyer P., Orrbine E., Klassen T.P., Wells G., MacKenzie A., Lior H., Blanchard C., Auclair F., Thompson B., Rafter D.J., McLaine P.N. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J. Infect. Dis. 171:1995;1042-1045.
7. 3), their natural receptor. J. Clin. Microbiol. 27:1989;1145-1150.
8. Blanco M., Blanco J., Blanco J.E., Ramos J. Enterotoxigenic, verotoxigenic, and necrotoxigenic Escherichia coli isolated from cattle in Spain. Am. J. Vet. Res. 54:1993;1446-1451.
9. Boulanger J., Huesca M., Arab S., Lingwood C.A. Universal method for the facile production of glycolipid/lipid matrices for the affinity purification of binding ligands. Anal. Biochem. 217:1994;1-6.
10. Burgess B.J., Roberts L.M. Proteolytic cleavage at arginine residues within the hydrophilic disulphide loop of the Escherichia coli Shiga-like toxin I A subunit is not essential for cytotoxicity. Mol. Microbiol. 10:1993;171-179.
11. Caprioli A., Nigrelli A., Gatti R., Zavanella M., Blando A.M., Minelli F., Donelli G. Characterisation of Verocytotoxin-producing Escherichia coli isolated from pigs and cattle in northern Italy. Vet. Rec. 133:1993;323-324.
12. Cordovéz A., Prado V., Maggi L., Cordero J., Martinez J., Misraji A., Rios R., Soza G., Ojeda A., Levine M.M. Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children. J. Clin. Microbiol. 30:1992;2153-2157.
13. DeGrandis S., Ginsberg J., Toone M., Climie S., Friesen J., Brunton J. Nucleotide sequence and promoter mapping of the Escherichia coli shiga-like toxin operon of bacteriophage H-19B. J. Bacteriol. 169:1987;4313-4319.
14. Donohue-Rolfe A., Acheson D.W.K., Kane A.V., Keusch G.T. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies. Infect. Immun. 57:1989;3888-3893.
15. Griffin P.M., Tauxe R.V. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13:1991;60-98.
16. Haddad J.E., Al-Jaufy A.Y., Jackson M.P. Minimum domain of the Shiga toxin A subunit required for enzymatic activity. J. Bacteriol. 175:1993;4970-4978.
17. Head S.C., Petric M., Richardson S., Roscoe M., Karmali M.A. Purification and characterization of verocytotoxin 2. FEMS Microbiol. Lett. 51:1988;211-216.
18. Huang A., DeGrandis S., Friesen J., Karmali M., Petric M., Congi R., Brunton J.L. Cloning and expression of the genes specifying shiga-like toxin production in Escherichia coli H19. J. Bacteriol. 166:1986;375-379.
19. Jackson M.P., Neill R.J., O'Brien A.D., Holmes R.K., Newland J.W. Nucleotide sequence analysis and comparison of the structural genes for shiga-like toxin I and shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol. Lett. 44:1987;109-114.
20. Karmali M.A., Petric M., Lim C., Cheung R., Arbus G.S. Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J. Clin. Microbiol. 22:1985;614-619.
21. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
22. Law D., Ganguli L.A., Donohue-Rolfe A., Acheson D.W.K. Detection by ELISA of low numbers of Shiga-like toxin-producing Escherichia coli in mixed cultures after growth in the presence of mitomycin C. J. Med. Microbiol. 36:1992;198-202.
23. Lemieux R.U., Bundle D.R., Baker D.A. The properties of a "synthetic" antigen related to the human blood-group Lewis a. J. Am. Chem. Soc. 97:1975;4076-4083.
24. Lingwood C.A. Verotoxins and their glycolipid receptors. Adv. Lipid Res. 25:1993;189-211.
25. Newland J.W., Strockbine N.A., Miller S.F., O'Brien A.D., Holmes R.K. Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli. Science. 230:1985;179-181.
26. O'Brien A.D., Holmes R.K. Shiga and shiga-like toxins. Microbiol. Rev. 51:1987;206-220.
27. Richter H., Klie H., Timm M., Gallien P., Steinruck H., Perlberg K.W., Protz D. Verotoxin producing E. coli (VTEC) in faeces from cattle slaughtered in Germany. Ber. Munch. Tierarz. Woch. 110:1997;121-127.
28. 2 subunits is not required for toxin activity. J. Biol. Chem. 269:1994;4853-4859.
29. Son R., Ansary A., Rusul G., Karim M.I.A. Isolation of Verotoxin producing Escherichia coli associated with diarrhoea in Malaysia containing plasmids showing homology with biotinylated Shiga like toxin DNA gene probes. World J. Microbiol. Biotechnol. 12:1996;243-246.
30. Vandekar N.C.A.J., Roelofs H.G.R., Muytjens H.L., Tolboom J.J.M., Roth B., Proesmans W., Wolff E.D., Karmali M.A., Chart H., Monnens L.A.H. Verocytotoxin producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe. Eur. J. Pediatr. 155:1996;592-595.
31. Voyer L.E., Wainsztein R.E., Quadri B.E., Corti S.E. Hemolytic uremic syndrome in families - An Argentinian experience. Pediatr. Nephrol. 10:1996;70-72.